Amlodipine and Hepatitis toxic - a phase IV clinical study of FDA data

Summary:

Hepatitis toxic is reported as a side effect among people who take Amlodipine (amlodipine besylate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Pantoprazole Sodium, and have Hyperlipidaemia.

The phase IV clinical study analyzes which people have Hepatitis toxic when taking Amlodipine. It is created by eHealthMe based on reports of 346,875 people who have side effects when taking Amlodipine from the FDA, and is updated regularly.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,830 Amlodipine users. Check the latest studies of Amlodipine.

What is Hepatitis toxic?

Hepatitis toxic is found to be associated with 281 drugs and 525 conditions by eHealthMe. Check the latest studies of Hepatitis toxic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

346,875 people reported to have side effects when taking Amlodipine.
Among them, 39 people (0.01%) have Hepatitis toxic.

Could Amlodipine cause Hepatitis toxic?

Among these 39 people:

How long have people been on Amlodipine when they have Hepatitis toxic? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Hepatitis toxic when taking Amlodipine? *

  • female: 64.1 %
  • male: 35.9 %

What is the age of people who have Hepatitis toxic when taking Amlodipine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 2.56 %
  • 40-49: 0.0 %
  • 50-59: 25.64 %
  • 60+: 71.79 %

What are other drugs people take besides Amlodipine? *

  1. Levothyroxine Sodium: 7 people, 17.95%
  2. Pantoprazole Sodium: 7 people, 17.95%
  3. Hydrochlorothiazide: 6 people, 15.38%
  4. Salagen: 6 people, 15.38%
  5. Simvastatin: 5 people, 12.82%
  6. Metformin: 5 people, 12.82%
  7. Omeprazole: 5 people, 12.82%
  8. Lenvatinib: 5 people, 12.82%
  9. Bosulif: 3 people, 7.69%
  10. Prednisone: 3 people, 7.69%

What are other side effects people have besides Hepatitis toxic? *

  1. Aspartate Aminotransferase Increased: 7 people, 17.95%
  2. Alanine Aminotransferase Increased: 7 people, 17.95%
  3. Nausea (feeling of having an urge to vomit): 7 people, 17.95%
  4. Nausea And Vomiting: 6 people, 15.38%
  5. Fever: 5 people, 12.82%
  6. Weakness: 5 people, 12.82%
  7. Ascites (accumulation of fluid in the abdominal cavity): 5 people, 12.82%
  8. Gamma-Glutamyltransferase Increased: 5 people, 12.82%
  9. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 10.26%
  10. Hepatic Function Abnormal: 4 people, 10.26%

What are the existing conditions these people have? *

  1. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 12.82%
  2. Ill-Defined Disorder: 3 people, 7.69%
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 7.69%
  4. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 7.69%
  5. Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 3 people, 7.69%
  6. Nausea (feeling of having an urge to vomit): 3 people, 7.69%
  7. Disseminated Tuberculosis: 2 people, 5.13%
  8. Enlarged Prostate: 2 people, 5.13%
  9. Gastritis (inflammation of stomach): 2 people, 5.13%
  10. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine and have Hepatitis toxic?

- Check whether Hepatitis toxic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amlodipine:

Hepatitis toxic treatments and more:

How severe was Hepatitis toxic and when was it recovered:

Expand to all the drugs that have ingredients of amlodipine besylate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis toxic:

Browse all the conditions that are associated with Hepatitis toxic:


How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Amlodipine) and Amlodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: